Literature DB >> 5082465

Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.

E V Adlin, A D Marks, B J Channick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5082465

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  19 in total

1.  [Plasma aldosterone and plasma renin activity in patients with essential and renal hypertension under acute stimulation with saline depletion and acute suppression with saline infusion].

Authors:  F Klumpp; D Klaus; R Lemke; J Zehner; P Zöfel
Journal:  Klin Wochenschr       Date:  1975-03-01

2.  Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.

Authors:  Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Journal:  Am J Hypertens       Date:  2010-08-19       Impact factor: 2.689

Review 3.  Stepped care for hypertension is dead, but what will replace it?

Authors:  J D Spence
Journal:  CMAJ       Date:  1989-05-15       Impact factor: 8.262

4.  Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study.

Authors:  P O Lim; R T Jung; T M MacDonald
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

5.  Hypotensive effects of sodium volume depletion and 1-sar-8-ala-angiotensin II in relation to plasma renin in hypertensive patients.

Authors:  R Fagard; A Amery; P Lijnen; T Reybrouck
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

Review 6.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

7.  Factors in the choice of antihypertensive therapy.

Authors:  A Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335

8.  [Antihypertensive effect of spironolactone (author's transl)].

Authors:  H Liebau; W Jarosch-von Schweder
Journal:  Klin Wochenschr       Date:  1974-09-01

Review 9.  Hirsutism and the effectiveness of spironolactone in its management.

Authors:  G R McMullen; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

10.  Renin concentrations and effects of propranolol and spironolactone in patients with hypertension.

Authors:  B E Karlberg; B Kågedal; L Tegler; K Tolagen
Journal:  Br Med J       Date:  1976-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.